ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
Yahoo Finance · Aug 13, 2026 · Phreesia Inc (PHR)
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +42.11% and -4.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Not investment advice. Cached headline, not a full reprint.